These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30022153)

  • 1. Cannabidiol does not display drug abuse potential in mice behavior.
    Viudez-Martínez A; García-Gutiérrez MS; Medrano-Relinque J; Navarrón CM; Navarrete F; Manzanares J
    Acta Pharmacol Sin; 2019 Mar; 40(3):358-364. PubMed ID: 30022153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol Modulates the Motivational and Anxiety-Like Effects of 3,4-Methylenedioxypyrovalerone (MDPV) in Mice.
    Alegre-Zurano L; López-Arnau R; Luján MÁ; Camarasa J; Valverde O
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal.
    Gasparyan A; Navarrete F; Rodríguez-Arias M; Miñarro J; Manzanares J
    Neurotherapeutics; 2021 Jan; 18(1):615-623. PubMed ID: 33230690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Cannabidiol in the Mouse Drug Discrimination Paradigm.
    Mustafa MA; Poklis JL; Karin KN; Elmer JA; Porter JH; Parra V; Lu D; Schlosburg JE; Lichtman AH
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):581-590. PubMed ID: 36656312
    [No Abstract]   [Full Text] [Related]  

  • 5. Cannabidiol (CBD) facilitates cocaine extinction and ameliorates cocaine-induced changes to the gut microbiome in male C57BL/6JArc mice.
    Chesworth R; Yim HC; Watt G; El-Omar E; Karl T
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111014. PubMed ID: 38649130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol Reduced the Severity of Gastrointestinal Symptoms of Opioid Withdrawal in Male and Female Mice.
    Scicluna RL; Wilson BB; Thelaus SH; Arnold JC; McGregor IS; Bowen MT
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):547-560. PubMed ID: 36577048
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential Effects of Cannabidiol and a Novel Cannabidiol Analog on Oxycodone Place Preference and Analgesia in Mice: an Opioid Abuse Deterrent with Analgesic Properties.
    Harris HM; Gul W; ElSohly MA; Sufka KJ
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):804-813. PubMed ID: 34962133
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabidiol as a potential cessation therapeutic: Effects on intravenous nicotine self-administration and withdrawal symptoms in mice.
    Cheeks SN; Buzzi B; Valdez A; Mogul AS; Damaj MI; Fowler CD
    Neuropharmacology; 2024 Mar; 246():109833. PubMed ID: 38176534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid.
    Majimbi M; Brook E; Galettis P; Eden E; Al-Salami H; Mooranian A; Al-Sallami H; Lam V; Mamo JCL; Takechi R
    PLoS One; 2021; 16(6):e0243858. PubMed ID: 34138862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice.
    Schleicher EM; Ott FW; Müller M; Silcher B; Sichler ME; Löw MJ; Wagner JM; Bouter Y
    Front Behav Neurosci; 2019; 13():94. PubMed ID: 31133833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cannabidiol on brain glucose metabolism of C57Bl/6 male mice previously exposed to cocaine.
    Spelta LEW; Real CC; Bruno V; Buchpiguel CA; Garcia RCT; Torres LH; de Paula Faria D; Marcourakis T
    J Neurosci Res; 2024 Apr; 102(4):e25327. PubMed ID: 38588037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Cannabidiol does not alter Alcohol Seeking and Self-Administration in Baboons.
    Moore CF; Zamarripa CA; Weerts EM
    Drug Alcohol Depend; 2023 Apr; 245():109829. PubMed ID: 36871377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced brain-targeting and efficacy of cannabidiol via RVG-Exo/CBD nanodelivery system.
    Li Y; Chen Z; Guo J; Meng D; Pang X; Sun Z; Pu L; Yang S; Yang M; Peng Y
    Biochem Biophys Res Commun; 2024 Sep; 725():150260. PubMed ID: 38878760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects.
    Hu Z; Qin Z; Xie J; Qu Y; Yin L
    Biomed Pharmacother; 2024 Jul; 176():116271. PubMed ID: 38788594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis sativa L. may reduce aggressive behaviour towards humans in shelter dogs.
    Corsetti S; Borruso S; Malandrucco L; Spallucci V; Maragliano L; Perino R; D'Agostino P; Natoli E
    Sci Rep; 2021 Feb; 11(1):2773. PubMed ID: 33531559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol-drug interaction in cancer patients: A retrospective study in a real-life setting.
    Guedon M; Le Bozec A; Brugel M; Clarenne J; Carlier C; Perrier M; Laurent M; Hettler D; Mongaret C; Bouché O; Slimano F
    Br J Clin Pharmacol; 2023 Jul; 89(7):2322-2328. PubMed ID: 36849134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards Better Delivery of Cannabidiol (CBD).
    Millar SA; Maguire RF; Yates AS; O'Sullivan SE
    Pharmaceuticals (Basel); 2020 Aug; 13(9):. PubMed ID: 32872355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol (CBD): Potential Use in Otorhinolaryngology.
    Jotz GP; Ortiz RS; Limberger RP; de Oliveira Camargo FA
    Int Arch Otorhinolaryngol; 2024 Jan; 28(1):e1-e2. PubMed ID: 38322448
    [No Abstract]   [Full Text] [Related]  

  • 19. Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship.
    Contin M; Mancinelli L; Perrone A; Sabattini L; Mohamed S; Scandellari C; Foschi M; Vacchiano V; Lugaresi A; Riva R
    Clin Neuropharmacol; 2018; 41(5):171-176. PubMed ID: 30024443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention.
    Leweke FM; Mueller JK; Lange B; Fritze S; Topor CE; Koethe D; Rohleder C
    CNS Drugs; 2018 Jul; 32(7):605-619. PubMed ID: 30022465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.